-
1
-
-
0023521261
-
3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in the treatment of hypercholesterolemia
-
J. M. Hoeg and H. B. Brewer, Jr. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in the treatment of hypercholesterolemia. J. Am. Med. Assoc. 258:3532-3536 (1987).
-
(1987)
J. Am. Med. Assoc.
, vol.258
, pp. 3532-3536
-
-
Hoeg, J.M.1
Brewer H.B., Jr.2
-
2
-
-
0028096810
-
A review of clinical trials comparing HMG-CoA reductase inhibitors
-
D. R. Illingworth and J. A. Tobert. A review of clinical trials comparing HMG-CoA reductase inhibitors. Clin. Ther. 16:366-385 (1994).
-
(1994)
Clin. Ther.
, vol.16
, pp. 366-385
-
-
Illingworth, D.R.1
Tobert, J.A.2
-
3
-
-
0025944198
-
Relative lipophilicities, solubilities, and structure-pharmacological consideration of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors pravastatin, lovastatin, mevastatin, and simvastatin
-
A. T. M. Serajuddin, S. A. Ranadive, and E. M. Mahoney. Relative lipophilicities, solubilities, and structure-pharmacological consideration of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors pravastatin, lovastatin, mevastatin, and simvastatin. J. Pharm. Sci. 80:830-834 (1991).
-
(1991)
J. Pharm. Sci.
, vol.80
, pp. 830-834
-
-
Serajuddin, A.T.M.1
Ranadive, S.A.2
Mahoney, E.M.3
-
4
-
-
0026591167
-
Carrier-mediated uptake of pravastatin by rat hepatocytes in primary culture
-
T. Komai, E. Shigehara, T. Tokui, T. Koga, M. Ishigami, C. Kuroiwa, and S. Horiuchi. Carrier-mediated uptake of pravastatin by rat hepatocytes in primary culture. Biochem. Pharmacol. 43:667-670 (1992).
-
(1992)
Biochem. Pharmacol.
, vol.43
, pp. 667-670
-
-
Komai, T.1
Shigehara, E.2
Tokui, T.3
Koga, T.4
Ishigami, M.5
Kuroiwa, C.6
Horiuchi, S.7
-
5
-
-
0027375980
-
Hepatoselective carrier-mediated sodium-independent uptake of pravastatin and pravastatin-lactone
-
K. Ziegler and S. Hummelsiep. Hepatoselective carrier-mediated sodium-independent uptake of pravastatin and pravastatin-lactone. Biochim. Biophys. Acta 1153:23-33 (1993).
-
(1993)
Biochim. Biophys. Acta
, vol.1153
, pp. 23-33
-
-
Ziegler, K.1
Hummelsiep, S.2
-
7
-
-
0022485201
-
CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: Tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal species
-
Y. Tsujita, M. Kuroda, Y. Shimada, K. Tanizawa, M. Arai, I. Kaneko, M. Tanaka, H. Masuda, C. Tarumi, Y. Watanabe, and S. Fuji. CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: Tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal species. Biochim. Biophys. Acta 877:50-60 (1986).
-
(1986)
Biochim. Biophys. Acta
, vol.877
, pp. 50-60
-
-
Tsujita, Y.1
Kuroda, M.2
Shimada, Y.3
Tanizawa, K.4
Arai, M.5
Kaneko, I.6
Tanaka, M.7
Masuda, H.8
Tarumi, C.9
Watanabe, Y.10
Fuji, S.11
-
8
-
-
0025286202
-
Tissue-selective inhibition of cholesterol synthesis in vitro by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor
-
T. Koga, Y. Shimada, M. Kuroda, Y. Tsujita, K. Hasegawa, and M. Yamazaki. Tissue-selective inhibition of cholesterol synthesis in vitro by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. Biochim. Biophys. Acta 1045:115-120 (1990).
-
(1990)
Biochim. Biophys. Acta
, vol.1045
, pp. 115-120
-
-
Koga, T.1
Shimada, Y.2
Kuroda, M.3
Tsujita, Y.4
Hasegawa, K.5
Yamazaki, M.6
-
9
-
-
0026641368
-
Tissue selectivity of pravastatin sodium, lovastatin and simvastatin
-
T. Koga, K. Fukuda, Y. Shimada, M. Fukami, H. Koike, and Y. Tsujita. Tissue selectivity of pravastatin sodium, lovastatin and simvastatin. Eur. J. Biochem. 209:315-319 (1992).
-
(1992)
Eur. J. Biochem.
, vol.209
, pp. 315-319
-
-
Koga, T.1
Fukuda, K.2
Shimada, Y.3
Fukami, M.4
Koike, H.5
Tsujita, Y.6
-
10
-
-
0028814860
-
Different effects of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors on sterol synthesis in various human cell types
-
A. K. van Vliet, G. C. F. van Thiel, R. H. Huisman, H. Moshage, S. H. Yap, and L. H. Cohen. Different effects of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors on sterol synthesis in various human cell types. Biochim. Biophys. Acta 1254:105-111 (1995).
-
(1995)
Biochim. Biophys. Acta
, vol.1254
, pp. 105-111
-
-
Van Vliet, A.K.1
Van Thiel, G.C.F.2
Huisman, R.H.3
Moshage, H.4
Yap, S.H.5
Cohen, L.H.6
-
11
-
-
0024330631
-
Quantitative evaluation of targeted drug delivery systems
-
P. K. Gupta and C. T. Hung. Quantitative evaluation of targeted drug delivery systems. Int. J. Pharm. 56:217-226 (1989).
-
(1989)
Int. J. Pharm.
, vol.56
, pp. 217-226
-
-
Gupta, P.K.1
Hung, C.T.2
-
12
-
-
0023104859
-
Targeted drug delivery: Some pharmacokinetic considerations
-
G. Levy. Targeted drug delivery: Some pharmacokinetic considerations. Pharm. Res. 4:3-4 (1987).
-
(1987)
Pharm. Res.
, vol.4
, pp. 3-4
-
-
Levy, G.1
-
13
-
-
0024373204
-
Pharmacokinetic and pharmacodynamic aspects of site-specific drug delivery
-
A. Boddy and L. Aarons. Pharmacokinetic and pharmacodynamic aspects of site-specific drug delivery. Adv. Drug Deliv. Rev. 3:155-163 (1989).
-
(1989)
Adv. Drug Deliv. Rev.
, vol.3
, pp. 155-163
-
-
Boddy, A.1
Aarons, L.2
-
14
-
-
0024508358
-
Tissue selectivity of the cholesterol-lowering agents lovastatin, simvastatin and pravastatin in rats in vivo
-
J. I. Germershausen, V. M. Hunt, R. G. Bostedor, P. J. Bailey, J. D. Karkas, and A. W. Alberts. Tissue selectivity of the cholesterol-lowering agents lovastatin, simvastatin and pravastatin in rats in vivo. Biochim. Biophys. Res. Commun. 158:667-675 (1989).
-
(1989)
Biochim. Biophys. Res. Commun.
, vol.158
, pp. 667-675
-
-
Germershausen, J.I.1
Hunt, V.M.2
Bostedor, R.G.3
Bailey, P.J.4
Karkas, J.D.5
Alberts, A.W.6
-
15
-
-
0001449559
-
The routine fitting of kinetic data to models: A mathematical formalism for digital computers
-
M. Berman, E. Shahn, and M. F. Weiss. The routine fitting of kinetic data to models: A mathematical formalism for digital computers. Biophys. J. 2:275-287 (1962).
-
(1962)
Biophys. J.
, vol.2
, pp. 275-287
-
-
Berman, M.1
Shahn, E.2
Weiss, M.F.3
-
16
-
-
0017055252
-
ML-236A, ML-236B and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrium
-
A. Endo, M. Kuroda, and Y. Tsujita. ML-236A, ML-236B and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrium. J. Antibiot. 29:1346-1348 (1977).
-
(1977)
J. Antibiot.
, vol.29
, pp. 1346-1348
-
-
Endo, A.1
Kuroda, M.2
Tsujita, Y.3
-
17
-
-
0017754661
-
Inhibition of cholesterol synthesis in vitro and in vivo by ML-236A and ML-236B, competitive inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase
-
A. Endo, Y. Tsujita, M. Kuroda, and K. Tanzawa. Inhibition of cholesterol synthesis in vitro and in vivo by ML-236A and ML-236B, competitive inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Eur. J. Biochem. 77:31-36 (1977).
-
(1977)
Eur. J. Biochem.
, vol.77
, pp. 31-36
-
-
Endo, A.1
Tsujita, Y.2
Kuroda, M.3
Tanzawa, K.4
-
18
-
-
0026567257
-
Hepatic and nonhepatic sterol synthesis and tissue distribution following administration of a liver selective HMG-CoA reductase inhibitor, CI-981: Comparison with selected HMG-CoA reductase inhibitors
-
T. M. A. Bocan, E. Ferguson, W. McNally, P. D. Uhlendorf, S. B. Muller, P. Dehart, D. R. Sliskovic, B. D. Roth, B. R. Krause, and R. S. Newton. Hepatic and nonhepatic sterol synthesis and tissue distribution following administration of a liver selective HMG-CoA reductase inhibitor, CI-981: Comparison with selected HMG-CoA reductase inhibitors. Biochim. Biophys. Acta 1123:133-144 (1992).
-
(1992)
Biochim. Biophys. Acta
, vol.1123
, pp. 133-144
-
-
Bocan, T.M.A.1
Ferguson, E.2
McNally, W.3
Uhlendorf, P.D.4
Muller, S.B.5
Dehart, P.6
Sliskovic, D.R.7
Roth, B.D.8
Krause, B.R.9
Newton, R.S.10
-
19
-
-
0026668094
-
Disposition and metabolism of pravastatin sodium in rats, dogs and monkeys
-
T. Komai, K. Kawai, T. Tokui, Y. Tokui, C. Kuroiwa, E. Shigehara, and M. Tanaka. Disposition and metabolism of pravastatin sodium in rats, dogs and monkeys. Eur. J. Drug Metab. Pharmacokin. 17:103-113 (1992).
-
(1992)
Eur. J. Drug Metab. Pharmacokin.
, vol.17
, pp. 103-113
-
-
Komai, T.1
Kawai, K.2
Tokui, T.3
Tokui, Y.4
Kuroiwa, C.5
Shigehara, E.6
Tanaka, M.7
-
20
-
-
0025355830
-
Disposition of pravastatin sodium, a tissue-selective HMG-CoA reductase inhibitor, in healthy subjects
-
S. M. Singhvi, H. Y. Pan, R. A. Morrison, and D. A. Willard. Disposition of pravastatin sodium, a tissue-selective HMG-CoA reductase inhibitor, in healthy subjects. Br. J. Clin. Pharmacol. 29:239-243 (1990).
-
(1990)
Br. J. Clin. Pharmacol.
, vol.29
, pp. 239-243
-
-
Singhvi, S.M.1
Pan, H.Y.2
Morrison, R.A.3
Willard, D.A.4
-
21
-
-
0025771262
-
Biotransformation of pravastatin sodium in human
-
D. W. Everett, T. J. Chando, G. C. Didonato, S. M. Singhvi, H. Y. Pan, and S. H. Weinstein. Biotransformation of pravastatin sodium in human. Drug Metab. Dispos. 19:740-748 (1991).
-
(1991)
Drug Metab. Dispos.
, vol.19
, pp. 740-748
-
-
Everett, D.W.1
Chando, T.J.2
Didonato, G.C.3
Singhvi, S.M.4
Pan, H.Y.5
Weinstein, S.H.6
-
22
-
-
0020279521
-
Physiological pharmacokinetics of ethoxybenzamide based on biochemical data obtained in vitro as well as on physiological data
-
J. H. Lin, Y. Sugiyama, S. Awazu, and M. Hanano. Physiological pharmacokinetics of ethoxybenzamide based on biochemical data obtained in vitro as well as on physiological data. J. Pharmacokin. Biopharm. 10:649-661 (1982).
-
(1982)
J. Pharmacokin. Biopharm.
, vol.10
, pp. 649-661
-
-
Lin, J.H.1
Sugiyama, Y.2
Awazu, S.3
Hanano, M.4
-
23
-
-
0028029150
-
Transcellular transport of benzoic acid across Caco-2 cells by a pH-dependent and carrier-mediated transport mechanism
-
A. Tsuji, H. Takanaga, I. Tamai, and T. Terasaki, Transcellular transport of benzoic acid across Caco-2 cells by a pH-dependent and carrier-mediated transport mechanism. Pharm. Res. 11:30-37 (1994).
-
(1994)
Pharm. Res.
, vol.11
, pp. 30-37
-
-
Tsuji, A.1
Takanaga, H.2
Tamai, I.3
Terasaki, T.4
-
24
-
-
0345482570
-
Pharmacokinetics of HMG-CoA reductase inhibitors
-
K. Sasahara. Pharmacokinetics of HMG-CoA reductase inhibitors. Prog. Med. 11:2413-2427 (1991).
-
(1991)
Prog. Med.
, vol.11
, pp. 2413-2427
-
-
Sasahara, K.1
-
25
-
-
0021961770
-
3-Hydroxy-3-methylglutaryl-coenzyme A reductase is present in peroxisome in normal rat liver cells
-
G. A. Keller, M. C. Barton, D. J. Shapiro, and S. J. Singer. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase is present in peroxisome in normal rat liver cells. Proc. Natl. Acad. Sci. U.S. 82:770-774 (1985).
-
(1985)
Proc. Natl. Acad. Sci. U.s.
, vol.82
, pp. 770-774
-
-
Keller, G.A.1
Barton, M.C.2
Shapiro, D.J.3
Singer, S.J.4
|